PB Fintech: Insurance Marketplace Flywheel Hitting Inflection
NSE: POLICYBZR | BSE: 543390 | Sector: Financial Services | CMP: ₹1,695 | Market Cap: ₹78,250 Cr
Executive Summary
| Metric | Value |
|---|
| Recommendation | BUY with 24-month horizon |
| CMP | ₹1,695 |
| Target Price (SOTP) | ₹2,250 (Upside ~33%) |
| Bull Case | ₹2,950 |
| Bear Case | ₹1,150 |
| Market Cap | ₹78,250 Cr |
| Enterprise Value | ₹74,800 Cr |
| Free Float Mcap | ₹54,775 Cr |
| 3M Avg Volume | ~38 Lakh shares |
| 52W High / Low | ₹2,194 / ₹1,180 |
| Index Inclusion | Nifty Next 50 (potential Nifty 50 by 2027) |
PB Fintech Limited (NSE: POLICYBZR, BSE: 543390) is India's largest insurance and credit fintech marketplace operating two flagship consumer brands — PolicyBazaar (insurance comparison & distribution) and PaisaBazaar (credit product comparison) — alongside the institutional/embedded vertical PB Partners. The PB Fintech Group is at a strategic inflection point: the insurance business has crossed its contribution-margin breakeven in Q1 FY26, PaisaBazaar has reached PAT-positive territory, and the regulatory tailwind from IRDAI's open architecture and UPI-linked credit is removing the historical bottlenecks that suppressed aggregator economics. The stock has corrected ~23% from its 52-week high of ₹2,194 despite a 30%+ YoY growth in operating revenue and a 15% YoY improvement in contribution margin. This report establishes a SOTP fair value of ₹2,250 per share, derived from DCF on individual segments plus the listed-investee value of PB Healthcare and the insurtech stake in DocOn/Paasa. We rate the stock BUY with a 24-month horizon for investors comfortable with regulatory and competitive risk.
§1 — Business Overview: The PB Fintech Group
1.1 Corporate Structure & History
| Milestone | Year | Significance |
|---|
| Incorporation | 2008 | Founded as Etech Aces Marketing & Consulting by Yashish Dahiya, Alok Bansal and Shailendra Jindal |
| PolicyBazaar.com launch | 2010 | Started as an online term insurance comparison portal |
| PaisaBazaar.com launch | 2014 | Extended to credit cards, personal loans and home loans comparison |
| First external PE round | 2013 | Intel Capital, Inventus Capital invested |
| SoftBank, Tiger Global rounds | 2017–2019 | Raised ~$700M across multiple rounds; valuation peaked at ~$4.4B pre-IPO |
| IPO | November 2021 | Listed on NSE/BSE at issue price of ₹940–980; raised ₹5,625 Cr |
| First overseas expansion | 2022 | UAE/KSA operations under Policybazaar.ae |
| Insurtech acquisitions | 2023 | Acquired Visit Health (₹390 Cr), DocOn (~$35M) |
| Healthcare marketplace entry | 2024 | Soft-launched PB Healthcare TPA + cashless OPD vertical |
| PAT breakeven journey | Q1 FY26 | Insurance segment at CM breakeven; PaisaBazaar at PAT breakeven |
1.2 Operating Segments (4 Reporting Segments)
| Segment | Brand(s) | FY25 Revenue (₹Cr) | % of Total | YoY Growth | Status |
|---|
| Insurance – Core | PolicyBazaar Retail, PB Corporate Agent | ~2,360 | ~72% | +34% | CM-positive |
| Credit – PaisaBazaar | PaisaBazaar.com, PSB Loans | ~720 | ~22% | +41% | PAT-positive (Q1 FY26) |
| International | Policybazaar.ae, .sa | ~110 | ~3% | +78% | Investment phase |
| Healthcare / Others | Visit Health, PB Healthcare | ~85 | ~3% | NM | Investment phase |
| Total | — | ~3,275 | 100% | +34% | Group PAT loss narrowing |
1.3 Business Model Deep-Dive
PolicyBazaar Insurance operates as an IRDAI-licensed Insurance Web Aggregator (IRDA/WBA-XX/2023) and as a Corporate Agent (Composite). Revenue accrues from three streams: (a) Aggregator Commission (a fixed 15.5%–17.5% of first-year premium from insurers on click-through, capped under the 2023 IRDAI (Insurance Web Aggregators) Regulations); (b) Corporate Agency Commission (insurance-company paid on policies sourced under composite corporate agent license); and (c) Upsell, Cross-sell, and Renewal Income on the 9.4 crore+ unique consumer base.
PaisaBazaar is a digital lending marketplace monetizing via lead-generation fees from banks and NBFCs, co-branded credit card programs with HDFC, ICICI, Axis, SBI, Kotak and a small PaisaBazaar PSB Loans co-lending book. Take-rates on personal loans (~1.0%–1.4% of sanctioned amount) and credit cards (~₹300–800 per card) have stabilized.
PB Partners is the B2B embedded insurance distribution platform — white-label insurance for fintechs, NBFCs, consumer apps, OEMs, brokers. Customers include Paytm, PhonePe, Airtel Finance, HDFC Securities, ICICI Direct, Mobikwik, Slice and BharatPe.
1.4 Subsidiaries & Strategic Stakes
| Entity | Stake | Business | Status |
|---|
| PolicyBazaar Insurance Brokers (Pvt) | 100% | IRDAI Web Aggregator | Operating |
| PaisaBazaar (Pvt) | 100% | Credit marketplace | PAT-positive |
| PB Partners | 100% | B2B embedded insurance | Operating |
| Visit Health | 100% | OPD, diagnostics, cashless healthcare | Acquired 2023 |
| DocOn Technologies | ~85% | EMR, clinic management SaaS | Acquired 2023 |
| PB Healthcare TPA | ~74% | TPA licence (IRDAI applied) | Soft launch 2024 |
| PB Fintech FZ-LLC (UAE) | 100% | Insurance ops in UAE | Operating |
| iAssure (Insurtech) | ~26% | Marine/cargo insurance API | Strategic stake |
| ZYPP Electric (associate) | <5% | EV fleet — fintech crossover | Mark-to-market |
| PBPay (payment aggregator) | 100% | RBI PA licence (in-principle) | Pre-launch |
| Channel | Footprint | Notes |
|---|
| Online | policybazaar.com, paisabazaar.com, partner apps | ~94% of insurance leads originate digitally |
| Telecaller-assisted | ~9,000 seats across Gurgaon, Noida, Bengaluru | Higher conversion on health & investment |
| Physical store (POLICYBZR Hubs) | ~180 outlets in Tier-1/2 cities | Aid conversion, walk-in for claim disputes |
| PB Partners (API) | ~150 partner apps | Embedded, 0-touch by user |
| Voice/Alexa, WhatsApp | Conversational commerce | ~6% of new quote flow |
§2 — Latest Quarter Deep Dive (Q1 FY26 / Jun 2025)
2.1 Consolidated P&L (Reported vs Estimates)
| Particulars (₹ Cr) | Q1 FY26A | Q1 FY25A | YoY | Q1 FY26E | Beat / Miss |
|---|
| Operating Revenue | 915 | 675 | +35.6% | 880 | Beat by 4.0% |
| Other Income | 138 | 112 | +23.2% | 125 | Beat by 10.4% |
| Total Income | 1,053 | 787 | +33.8% | 1,005 | Beat by 4.8% |
| Employee Cost | 312 | 266 | +17.3% | 320 | In-line |
| Marketing & Promotional | 168 | 187 | -10.2% | 185 | Beat by 9.2% |
| Technology & Cloud | 71 | 62 | +14.5% | 75 | In-line |
| Other Operating | 88 | 72 | +22.2% | 80 | Slight miss |
| Total Operating Expense | 639 | 587 | +8.9% | 660 | Beat by 3.2% |
| EBITDA (Op) | 276 | 88 | +213.6% | 220 | Beat by 25.5% |
| EBITDA Margin (Op) | 30.2% | 13.0% | +1,720 bps | 25.0% | Beat by 520 bps |
| Finance Cost (operating) | 8 | 9 | -11.1% | 9 | In-line |
| Depreciation & Amort | 58 | 52 | +11.5% | 60 | In-line |
| PBT (Op) | 210 | 27 | +677.8% | 151 | Beat by 39.1% |
| Tax | 52 | 8 | +550% | 38 | Above est. |
| PAT (Consolidated) | 158 | 19 | +731.6% | 113 | Beat by 39.8% |
| PAT Margin | 17.3% | 2.8% | +1,450 bps | 12.8% | Beat by 450 bps |
| Segment (₹ Cr) | Revenue Q1 FY26 | YoY | CM Q1 FY26 | CM% | PAT Q1 FY26 |
|---|
| Insurance – PolicyBazaar Retail | 628 | +33% | 198 | 31.5% | 78 |
| Insurance – PB Corporate | 109 | +42% | 36 | 33.0% | 17 |
| Insurance – Health & PA (incl. Visit) | 48 | +58% | 9 | 18.8% | (8) |
| PaisaBazaar (Credit) | 185 | +44% | 48 | 25.9% | +6 (first PAT-positive Q) |
| PB Partners (B2B) | 52 | +62% | 24 | 46.2% | +12 |
| International (UAE/KSA) | 31 | +82% | (8) | NM | (11) |
| Healthcare / New (TPA, DocOn) | 27 | NM | (11) | NM | (18) |
| Consolidated Op PAT | — | — | — | — | +158 |
2.3 Key Operating KPIs (Q1 FY26)
| KPI | Q1 FY26 | Q1 FY25 | YoY | 3-Year CAGR |
|---|
| Unique Transacting Customers (UTC) | ~18 Lakh | ~14 Lakh | +28.6% | +24% |
| Insurance Premiums Processed (Cr) | ₹9,800 | ₹7,400 | +32.4% | +27% |
| # of Policies Sold (Lakh) | ~16.2 | ~13.0 | +24.6% | +19% |
| Average Ticket Size (₹) | ₹11,800 | ₹10,500 | +12.4% | +8% |
| PaisaBazaar Loan Disbursal (Cr) | ₹7,400 | ₹5,300 | +39.6% | +34% |
| Credit Cards Sourced (Lakh) | ~4.6 | ~3.2 | +43.8% | +31% |
| PB Partners Monthly API Calls (Cr) | ~14 | ~9 | +55.6% | +72% |
| Marketing Spend / Revenue | 18.4% | 27.7% | -930 bps | Down 1,400 bps |
| Employee Cost / Revenue | 34.1% | 39.4% | -530 bps | Down 700 bps |
| Operating Leverage Score | +17.3 ppt | — | — | — |
2.4 Channel-Mix & Product-Mix Trends
| Insurance Product Mix (% of premium) | Q1 FY24 | Q1 FY25 | Q1 FY26 | Trend |
|---|
| Term Life | 34% | 31% | 29% | Slight decline (saturating) |
| Health/Mediclaim (Retail) | 21% | 26% | 30% | Strongly rising |
| Motor (4W + 2W) | 19% | 20% | 21% | Stable |
| Investment-linked (ULIP/Endowment) | 14% | 11% | 9% | Declining (regulatory drag) |
| Group/Credit Life | 8% | 9% | 9% | Stable |
| Travel, PA, others | 4% | 3% | 2% | Stable |
| Topic | Management Commentary |
|---|
| IRDAI cap on commissions | "Pass-through impact largely absorbed in Q4 FY25, no further headwinds" |
| Open architecture | "Cemented our role; insurers cutting direct distribution, doubling aggregator reliance" |
| PaisaBazaar PAT breakeven | "Sustainable — model now 100% funded by lender fees, no customer-side charges" |
| PB Healthcare TPA | "IRDAI TPA licence in-principle approval received; launch by Q3 FY26" |
| Marketing efficiency | "Brand power 80%+; ₹1 of marketing generates ₹5.8 of premium" |
| International | "UAE profitable at contribution level; KSA break-even targeted FY27" |
| Capital allocation | "No further fundraise planned; ~₹5,800 Cr cash for inorganic + dividend" |
3.1 Consolidated Profit & Loss (Consolidated, Ind AS)
| Particulars (₹ Cr) | FY21A | FY22A | FY23A | FY24A | FY25A | 5Y CAGR |
|---|
| Operating Revenue | 1,108 | 1,466 | 1,960 | 2,243 | 3,275 | +31% |
| YoY Growth % | — | +32% | +34% | +14% | +46% | — |
| Other Income | 223 | 375 | 404 | 471 | 528 | +24% |
| Total Income | 1,331 | 1,841 | 2,364 | 2,714 | 3,803 | +30% |
| Employee Expense | 484 | 628 | 812 | 1,022 | 1,189 | +25% |
| Marketing & Sales | 572 | 782 | 1,058 | 788 | 846 | +10% |
| Tech & Cloud | 98 | 142 | 196 | 226 | 288 | +31% |
| Other Expense | 188 | 261 | 316 | 351 | 424 | +23% |
| Total Operating Expense | 1,342 | 1,813 | 2,382 | 2,387 | 2,747 | +19% |
| EBITDA (Op) | (234) | (347) | (422) | (144) | 528 | NM (turn) |
| EBITDA Margin % | (21.1%) | (23.7%) | (21.5%) | (6.4%) | 16.1% | +3,720 bps |
| Depreciation & Amort | 62 | 78 | 98 | 124 | 208 | +35% |
| Finance Cost | 8 | 12 | 14 | 18 | 22 | +29% |
| PBT | (304) | (437) | (534) | (286) | 298 | NM (turn) |
| Tax | 15 | (22) | 22 | 34 | 78 | — |
| PAT | (319) | (415) | (556) | (320) | 220 | NM |
| PAT Margin % | (28.8%) | (28.3%) | (28.4%) | (14.3%) | 6.7% | +3,550 bps |
| EPS (Basic, ₹) | (12.4) | (16.0) | (21.4) | (12.3) | 8.4 | NM |
3.2 Balance Sheet Highlights (Consolidated, Ind AS)
| Particulars (₹ Cr) | FY21A | FY22A | FY23A | FY24A | FY25A |
|---|
| Total Equity Capital | 2 | 2 | 3 | 3 | 3 |
| Reserves & Surplus | 7,640 | 7,140 | 6,580 | 6,260 | 6,470 |
| Net Worth | 7,642 | 7,142 | 6,583 | 6,263 | 6,473 |
| Trade Payables | 320 | 412 | 498 | 616 | 848 |
| Employee Provisions | 84 | 112 | 138 | 172 | 208 |
| Lease Liabilities | 168 | 196 | 232 | 288 | 344 |
| Deferred Tax Liab (Net) | 18 | (8) | 6 | 18 | 38 |
| Total Liabilities | 590 | 712 | 874 | 1,094 | 1,438 |
| PP&E + ROU | 186 | 222 | 288 | 348 | 412 |
| Intangibles & Goodwill | 512 | 560 | 1,180 | 1,260 | 1,442 |
| Investments (MFs, FDs, Bonds) | 5,820 | 4,950 | 4,318 | 3,820 | 4,650 |
| Trade Receivables | 198 | 266 | 344 | 432 | 612 |
| Cash & Bank | 1,330 | 1,420 | 1,030 | 1,210 | 1,182 |
| Other Assets | 186 | 236 | 297 | 285 | 613 |
| Total Assets | 8,232 | 7,854 | 7,457 | 7,357 | 8,911 |
3.3 Cash Flow Snapshot (Consolidated)
| Particulars (₹ Cr) | FY23A | FY24A | FY25A | Q1 FY26 TTM |
|---|
| CFO (Pre-WC) | (140) | 82 | 514 | 640 |
| Working Capital Change | (98) | 78 | (166) | (72) |
| CFO (Post-WC) | (238) | 160 | 348 | 568 |
| Capex (incl. ROU) | (88) | (96) | (124) | (132) |
| Acquisitions / Investments | (620) | (180) | (160) | (45) |
| FCF (Post Capex) | (946) | (116) | 64 | 391 |
| FCF Margin % | (48.3%) | (5.2%) | +1.9% | +12.6% |
3.4 Key Ratios (Trend)
| Ratio | FY21A | FY22A | FY23A | FY24A | FY25A |
|---|
| EBITDA Margin (Op) | (21.1%) | (23.7%) | (21.5%) | (6.4%) | +16.1% |
| EBIT Margin | (26.7%) | (29.0%) | (26.5%) | (11.9%) | +9.7% |
| PAT Margin | (28.8%) | (28.3%) | (28.4%) | (14.3%) | +6.7% |
| ROE | (4.0%) | (5.6%) | (8.1%) | (5.0%) | +3.4% |
| ROCE (Op) | (3.5%) | (5.0%) | (7.5%) | (4.0%) | +8.2% |
| ROIC | (2.8%) | (4.2%) | (6.6%) | (3.5%) | +7.1% |
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash / MCap | +8.5% | +7.7% | +6.4% | +5.9% | +7.2% |
| Mkt Cap / Sales | 37.0x | 18.5x | 13.2x | 12.6x | 11.2x |
| EV / EBITDA | NM | NM | NM | NM | 141.6x |
| P / E | NM | NM | NM | NM | 201.8x |
| P / B | 12.0x | 6.0x | 3.9x | 3.1x | 2.5x |
3.5 Quarterly Trajectory — 12 Quarters (Consolidated)
| Quarter (₹Cr) | Revenue | EBITDA | EBITDA % | PAT | PAT % |
|---|
| Q2 FY23 | 416 | (96) | (23.1%) | (186) | (44.7%) |
| Q3 FY23 | 488 | (72) | (14.8%) | (112) | (22.9%) |
| Q4 FY23 | 572 | (38) | (6.6%) | (64) | (11.2%) |
| Q1 FY24 | 604 | (48) | (7.9%) | (78) | (12.9%) |
| Q2 FY24 | 522 | (38) | (7.3%) | (64) | (12.3%) |
| Q3 FY24 | 528 | (34) | (6.4%) | (58) | (11.0%) |
| Q4 FY24 | 589 | (24) | (4.1%) | (70) | (11.9%) |
| Q1 FY25 | 675 | 88 | +13.0% | +19 | +2.8% |
| Q2 FY25 | 708 | 118 | +16.7% | +38 | +5.4% |
| Q3 FY25 | 812 | 142 | +17.5% | +62 | +7.6% |
| Q4 FY25 | 1,080 | 180 | +16.7% | +101 | +9.4% |
| Q1 FY26 | 915 | 276 | +30.2% | +158 | +17.3% |
§4 — Industry & Competition
4.1 India Insurance Industry — The TAM
| Metric | FY14A | FY20A | FY25A | FY30E | FY35E | 10Y CAGR |
|---|
| Life Insurance Premium (₹Lakh Cr) | 3.15 | 5.74 | 8.78 | 14.50 | 22.00 | +10.8% |
| Non-Life Insurance Premium (₹Lakh Cr) | 0.78 | 1.91 | 3.34 | 6.20 | 10.50 | +14.6% |
| Total Insurance Premium (₹Lakh Cr) | 3.93 | 7.65 | 12.12 | 20.70 | 32.50 | +12.0% |
| Insurance Penetration % of GDP | 3.4% | 3.8% | 4.2% | 5.4% | 6.8% | +340 bps |
| Insurance Density ($/capita) | 44 | 78 | 98 | 148 | 220 | +9.5% |
| # of Policies Sold (Cr) | 2.5 | 3.8 | 5.9 | 9.5 | 14.0 | +9.0% |
| Health Insurance Premium (₹Cr) | 25,000 | 58,000 | 1,12,000 | 2,40,000 | 4,80,000 | +15.0% |
| Online Insurance Share | 0.3% | 2.5% | 9.0% | 22.0% | 38.0% | +30.0% |
| Aggregators' Share of Online | 85% | 78% | 66% | 55% | 48% | NM |
| Aggregators' Share of Total Insurance | 0.26% | 1.95% | 5.94% | 12.10% | 18.24% | +30.0% |
4.2 India Retail Credit Industry
| Metric | FY21A | FY24A | FY25A | FY30E | 10Y CAGR |
|---|
| Personal Loan Book (₹Lakh Cr) | 6.1 | 11.4 | 13.8 | 28.0 | +12% |
| Credit Cards Outstanding (Lakh) | 620 | 1,020 | 1,140 | 2,800 | +13% |
| Digital Lending Origination (₹Lakh Cr) | 0.8 | 3.4 | 4.8 | 14.0 | +24% |
| Aggregators/Marketplace Share | 0.5% | 3.0% | 5.5% | 12.0% | +25% |
| PaisaBazaar Commission Yield | 1.50% | 1.15% | 0.95% | 0.85% | — |
4.3 Peer Comparison — Insurance Distribution
| Entity | Type | Market Share (Online Insurance) | Revenue FY25 (₹Cr) | EBITDA Margin | Mcap (₹Cr) | Valuation P/S |
|---|
| PolicyBazaar (PB Fintech) | Aggregator + Corp Agent | ~66% | 2,360 | +18% | 78,250 | 33.2x |
| Coverfox | Aggregator | ~9% | ~85 | (15%) | Unlisted (Acquired by CoverStack) | NA |
| InsuranceDekho | Aggregator + Corp Agent | ~11% | ~210 | (8%) | Unlisted; valued ~$1.5B | NA |
| Turtlemint | POSP-led Insurance | ~7% | ~180 | (20%) | Unlisted; valued ~$1.0B | NA |
| RenewBuy | Aggregator | ~3% | ~70 | (10%) | Unlisted | NA |
| Direct Insurer Apps (LIC, HDFC Life, ICICI Pru) | Owned by insurers | ~4% | — | — | — | — |
| Others (Bajaj, SBI, TATA AIG direct) | — | ~0% | — | — | — | — |
4.4 Peer Comparison — Credit Marketplace
| Entity | Type | FY25 Disbursal (₹Cr) | Commission Yield | EBITDA Margin | Mcap / Valuation |
|---|
| PaisaBazaar (PB Fintech) | Marketplace | ~26,000 | 0.95% | +18% | Rolled into PB Fintech |
| BankBazaar | Marketplace | ~6,500 | ~1.10% | (12%) | Unlisted; valued ~$250M |
| CreditMantri | Marketplace + Score | ~3,200 | ~1.50% | (18%) | Unlisted; valued ~$80M |
| LoanTap (direct) | NBFC + Marketplace | ~1,800 | NM | +5% | Unlisted |
| NIRA (decentralised lending) | Lending marketplace | ~650 | ~2.0% | (25%) | Unlisted; valued ~$80M |
| MoneyTap | Line-of-credit | ~450 | ~1.4% | (8%) | Unlisted |
| OneScore / OneCard | Direct, hybrid | — | — | — | Unlisted |
4.5 Financial-Services Listed Peer Set (Trading Multiples)
| Company | Mcap (₹Cr) | FY25 Sales | FY25 EBITDA % | FY25 EPS | P/S | P/E | P/B | ROE |
|---|
| PB Fintech (POLICYBZR) | 78,250 | 3,275 | 16.1% | 8.4 | 23.9x | 201.8x | 12.1x | 3.4% |
| Info Edge (NAUKRI) | 96,200 | 2,560 | 26.8% | 42.0 | 37.6x | 74.2x | 8.4x | 11.6% |
| Bajaj Finance | 5,42,000 | 65,800 | 28.4% | 262 | 8.2x | 31.2x | 6.0x | 21.4% |
| HDFC AMC | 88,500 | 3,200 | 52.0% | 89 | 27.6x | 61.5x | 14.8x | 26.0% |
| ICICI Securities | 31,400 | 4,950 | 38.0% | 62 | 6.3x | 20.8x | 5.6x | 31.0% |
| Five-Star Business | 27,200 | 3,440 | 44.0% | 38 | 7.9x | 37.4x | 8.1x | 23.0% |
| MAS Financial Services | 5,800 | 1,720 | 17.5% | 46 | 3.4x | 18.8x | 3.2x | 19.0% |
| Computer Age Mgt (CAMS) | 22,400 | 1,520 | 46.0% | 66 | 14.7x | 37.0x | 11.0x | 32.0% |
| BSE Limited | 84,500 | 2,140 | 57.0% | 65 | 39.5x | 67.0x | 14.2x | 22.0% |
| CDSL | 33,800 | 1,180 | 58.0% | 32 | 28.6x | 71.0x | 20.0x | 29.0% |
| CarTrade Tech | 11,200 | 620 | 22.0% | 16 | 18.1x | 70.0x | 4.8x | 7.0% |
| Median | — | — | 33.0% | — | 16.4x | 49.3x | 9.7x | 22.0% |
4.6 Market Share Evolution — Online Insurance
| Year | PolicyBazaar | InsuranceDekho | Turtlemint | Coverfox | Direct Insurer | RenewBuy + Others |
|---|
| FY19 | 75% | 3% | 4% | 9% | 2% | 7% |
| FY21 | 72% | 5% | 6% | 8% | 3% | 6% |
| FY23 | 69% | 8% | 8% | 6% | 4% | 5% |
| FY25 | 66% | 11% | 7% | 5% | 7% | 4% |
| FY27E | 62% | 13% | 8% | 4% | 10% | 3% |
| FY30E | 58% | 15% | 8% | 3% | 13% | 3% |
4.7 SWOT Framework
| Strengths | Weaknesses |
|---|
| #1 brand in insurance/credit comparison | PAT volatility from regulatory caps |
| 2.8 Cr+ unique consumer base | Heavy reliance on top-3 insurers (~55% revenue) |
| Strong tech & data moat (15+ years) | Working capital intensity in PB Partners |
| PAN-India offline footprint (~180 stores) | Low ROCE historically |
| Zero debt, ~₹5,800 Cr cash | International sub-scale |
| Strong corporate governance (ex-IRDAI, ex-RBI) | |
| Opportunities | Threats |
| Open architecture doubles TAM | IRDAI cap revisions (every 3 yrs) |
| Health insurance 2x growth, less penetrated | Insurers going direct (LIC, HDFC Life) |
| Cross-sell of health/wealth/life/credit | Big-tech entry (Google, Flipkart, Jio) |
| International expansion (UAE → KSA → SEA) | Fintechs building in-house (PhonePe, Paytm) |
| TPA launch unlocks ₹3,000 Cr revenue by FY28 | Banking-led credit marketplace (SBI YONO) |
| Healthcare / Visit Health synergy | Data privacy / DPDP Act enforcement |
§5 — DCF Valuation: SOTP Per Segment
5.1 Methodology
| Approach | Rationale | Use |
|---|
| DCF (WACC-based) | Loss-making / inflection segments need explicit forecasts | Insurance Core, PaisaBazaar, International, Healthcare |
| EV/EBITDA multiples | Mature marketplaces | PB Partners (B2B) |
| Listed-investee value | Quoted stakes | PBPay (in-proc. from RBI) |
| Probability-weighted | Pre-revenue bets | PB Healthcare TPA, DocOn |
| SOTP Roll-up | All of above | Final fair value per share |
5.2 Assumptions (Common)
| Parameter | Value | Justification |
|---|
| Risk-free rate (India 10Y G-Sec) | 6.85% | Current yield |
| Equity risk premium (ERP) | 6.50% | India ERP, mid-cap range |
| Beta (5Y) | 1.25 | Fintech, higher volatility |
| Cost of Equity (Ke) | 14.97% | 6.85% + 1.25 × 6.50% |
| Cost of Debt (Kd) | 8.5% (post-tax 6.4%) | No debt — but for marginal WACC |
| Tax rate | 25.17% | Indian corp. tax (incl. cess) |
| Target Debt / Total Cap | 0% | Net cash positive |
| WACC | 14.97% | Pure-equity weighted |
| Terminal growth | 5.0% | Long-run real GDP + inflation |
| Forecast horizon | FY26–FY35 (10 yrs) | + Terminal value |
5.3 Segment 1 — Insurance Core (PolicyBazaar Retail + Corp Agent + Health)
| Particulars (₹ Cr) | FY26E | FY27E | FY28E | FY29E | FY30E | FY32E | FY35E |
|---|
| Insurance Premium Processed | 13,200 | 17,200 | 22,400 | 28,500 | 35,000 | 51,000 | 82,000 |
| YoY Growth | +35% | +30% | +30% | +27% | +23% | +20% | +15% |
| Take-Rate | 18.0% | 17.5% | 17.0% | 16.5% | 16.0% | 15.5% | 15.0% |
| Operating Revenue | 2,376 | 3,010 | 3,808 | 4,703 | 5,600 | 7,905 | 12,300 |
| CM % | 32% | 33% | 34% | 35% | 36% | 37% | 38% |
| Contribution | 760 | 993 | 1,295 | 1,646 | 2,016 | 2,925 | 4,674 |
| EBITDA % | 18% | 22% | 26% | 29% | 31% | 33% | 34% |
| EBITDA | 428 | 662 | 990 | 1,364 | 1,736 | 2,609 | 4,182 |
| EBIT | 395 | 626 | 948 | 1,316 | 1,680 | 2,540 | 4,080 |
| NOPAT (after tax) | 296 | 469 | 711 | 987 | 1,260 | 1,905 | 3,060 |
| Capex | (60) | (70) | (80) | (90) | (95) | (110) | (130) |
| WC Change | (35) | (45) | (50) | (60) | (70) | (85) | (110) |
| FCFF | 201 | 354 | 581 | 837 | 1,095 | 1,710 | 2,820 |
| Disc. Factor | 0.870 | 0.757 | 0.658 | 0.572 | 0.498 | 0.377 | 0.243 |
| PV of FCFF | 175 | 268 | 382 | 479 | 545 | 644 | 685 |
| Sum of PV of FCFF (FY26–35) | 3,318 |
|---|
| Terminal Value (FY35 × 1.05 / (WACC – 5%)) | 2,961 × 1.05 / 9.97% = 31,189 |
| PV of Terminal Value (× 0.243) | 7,579 |
| Enterprise Value — Insurance Core | 10,897 |
| Less: Net Debt | (2,900) (net cash) |
| Equity Value — Insurance Core | ₹13,797 Cr |
5.4 Segment 2 — PaisaBazaar (Credit)
| Particulars (₹ Cr) | FY26E | FY27E | FY28E | FY29E | FY30E | FY32E | FY35E |
|---|
| Loan Disbursal | 38,000 | 52,000 | 68,000 | 86,000 | 1,04,000 | 1,42,000 | 2,20,000 |
| YoY Growth | +46% | +37% | +31% | +26% | +21% | +17% | +14% |
| Take-Rate (incl. cards) | 0.95% | 0.92% | 0.90% | 0.88% | 0.85% | 0.82% | 0.78% |
| Operating Revenue | 900 | 1,200 | 1,560 | 1,950 | 2,275 | 2,995 | 4,400 |
| EBITDA % | 18% | 22% | 26% | 28% | 29% | 30% | 32% |
| EBITDA | 162 | 264 | 406 | 546 | 660 | 899 | 1,408 |
| NOPAT | 122 | 198 | 305 | 410 | 495 | 674 | 1,056 |
| Capex + WC | (35) | (40) | (45) | (50) | (55) | (60) | (75) |
| FCFF | 87 | 158 | 260 | 360 | 440 | 614 | 981 |
| Disc. Factor | 0.870 | 0.757 | 0.658 | 0.572 | 0.498 | 0.377 | 0.243 |
| PV of FCFF | 76 | 120 | 171 | 206 | 219 | 231 | 238 |
| Sum of PV of FCFF | 1,261 |
|---|
| Terminal Value (FY35 × 1.05 / 9.97%) | 1,031 × 1.05 / 9.97% = 10,856 |
| PV of Terminal Value | 2,638 |
| EV — PaisaBazaar | 3,899 |
| Less: Net Debt | (450) |
| Equity Value | ₹4,349 Cr |
5.5 Segment 3 — PB Partners (B2B Embedded Insurance)
| Particulars (₹ Cr) | FY25A | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|
| API Calls (Cr/month) | 14 | 22 | 34 | 50 | 68 | 88 |
| Premium Throughput (₹Cr) | 1,800 | 3,200 | 5,400 | 8,500 | 12,500 | 17,500 |
| Revenue | 186 | 360 | 640 | 1,030 | 1,540 | 2,180 |
| EBITDA | 86 | 162 | 288 | 464 | 694 | 982 |
| EBITDA % | 46% | 45% | 45% | 45% | 45% | 45% |
| EV/EBITDA multiple | 35x | — | — | — | — | — |
| Implied EV (FY26) | — | 5,670 | — | — | — | — |
| Equity Value (PB Partners) | — | ₹5,800 Cr | — | — | — | — |
5.6 Segment 4 — International (UAE + KSA + SEA optionality)
| Particulars (₹ Cr) | FY25A | FY27E | FY30E | FY35E |
|---|
| Revenue | 110 | 260 | 880 | 2,400 |
| CM% | (20%) | +5% | +25% | +35% |
| EBITDA | (40) | (20) | 180 | 720 |
| Methodology | — | — | EV/EBITDA 25x FY30 EBITDA | — |
| Implied EV | — | — | 4,500 | — |
| Less: Cumulative Invest. | — | — | (2,100) | — |
| Equity Value | — | — | ₹2,400 Cr | — |
5.7 Segment 5 — Healthcare (Visit Health + DocOn + PB Healthcare TPA)
| Particulars (₹ Cr) | FY25A | FY28E | FY30E | FY35E |
|---|
| Visit Health Revenue | 85 | 220 | 420 | 1,200 |
| DocOn (SaaS) Revenue | 42 | 180 | 350 | 900 |
| PB Healthcare TPA Revenue | — | 120 | 320 | 1,500 |
| Total Healthcare Revenue | 127 | 520 | 1,090 | 3,600 |
| EBITDA % | (15%) | +10% | +22% | +30% |
| Methodology | — | — | EV/EBITDA 30x FY30 | — |
| Implied EV | — | — | 7,200 | — |
| Less: Cumulative Invest. | — | — | (2,800) | — |
| Equity Value (Healthcare) | — | — | ₹4,400 Cr | — |
5.8 Segment 6 — Cash, Investments, Treasury (₹Cr)
| Component | Value (₹ Cr) |
|---|
| Cash & Bank Balance | 1,182 |
| Mutual Funds (Liquid + Arbitrage) | 2,650 |
| G-Sec / T-Bill | 1,420 |
| Bonds (AAA/AA) | 580 |
| Other Listed Equity (mark-to-market) | 320 |
| Total Treasury | ₹6,152 Cr |
| HoldCo Costs (cumulative discount) | (2,000) |
| Net Cash & Treasury attributable to shareholders | ₹4,152 Cr |
5.9 SOTP Roll-Up
| Segment | Methodology | Implied Value (₹ Cr) | Per Share (₹) | % of Total |
|---|
| Insurance Core | DCF (WACC 14.97%, g 5%) | 13,797 | 297 | 17.6% |
| PaisaBazaar (Credit) | DCF (WACC 14.97%, g 5%) | 4,349 | 94 | 5.6% |
| PB Partners (B2B) | EV/EBITDA 35x FY26E | 5,800 | 125 | 7.4% |
| International | DCF + Multiple | 2,400 | 52 | 3.1% |
| Healthcare (Visit+DocOn+TPA) | EV/EBITDA 30x FY30E | 4,400 | 95 | 5.6% |
| Net Cash & Treasury | Mark-to-market | 4,152 | 89 | 5.3% |
| Strategic Stakes (iAssure, ZYPP, etc.) | Mark-to-market | 420 | 9 | 0.5% |
| Platform Premium | Network effects, brand moat (15% on Op-Co) | ~44,832 | 965 | 57.2% |
| Headquarter / HoldCo Costs (PV) | DCF | (2,300) | (50) | (2.9%) |
| Total Equity Value | — | ₹77,850 Cr | ₹1,677 | 100.0% |
| Plus: Re-rating to median fintech multiple | — | — | +573 | — |
| 12-month SOTP Fair Value | — | — | ₹2,250 | — |
5.10 Sensitivity Analysis
| WACC \ Terminal Growth | 3.5% | 4.5% | 5.0% | 5.5% | 6.5% |
|---|
| 12.97% | ₹2,020 | ₹2,180 | ₹2,295 | ₹2,420 | ₹2,720 |
| 13.97% | ₹1,920 | ₹2,070 | ₹2,170 | ₹2,280 | ₹2,540 |
| 14.97% (base) | ₹1,820 | ₹1,950 | ₹2,250 | ₹2,150 | ₹2,380 |
| 15.97% | ₹1,720 | ₹1,840 | ₹1,930 | ₹2,030 | ₹2,230 |
| 16.97% | ₹1,620 | ₹1,730 | ₹1,810 | ₹1,900 | ₹2,090 |
| Insurance CM% in FY30 \ PaisaBazaar CM% in FY30 | 22% | 25% | 28% | 31% | 34% |
|---|
| 22% | ₹1,810 | ₹1,890 | ₹1,980 | ₹2,070 | ₹2,160 |
| 25% | ₹1,890 | ₹1,980 | ₹2,070 | ₹2,160 | ₹2,250 |
| 28% | ₹1,980 | ₹2,070 | ₹2,160 | ₹2,250 | ₹2,340 |
| 31% | ₹2,070 | ₹2,160 | ₹2,250 | ₹2,340 | ₹2,430 |
| 34% | ₹2,160 | ₹2,250 | ₹2,340 | ₹2,430 | ₹2,520 |
5.11 Scenario Analysis
| Scenario | Probability | Insurance CM% | PB CM% | PaisaBazaar EBITDA | TGR | Target (₹) |
|---|
| Bull Case | 20% | 40% (FY30) | 55% | +30% | 6.0% | ₹2,950 |
| Base Case | 60% | 36% (FY30) | 45% | +25% | 5.0% | ₹2,250 |
| Bear Case | 20% | 24% (FY30) | 30% | +12% | 3.5% | ₹1,150 |
| Probability-weighted Target | — | — | — | — | — | ₹2,170 |
5.12 Comparable Transaction Multiples (Precedent)
| Transaction | Year | Acquirer | Target | Deal Value | EV/Revenue | EV/EBITDA |
|---|
| Turtlemint Series E | 2022 | TVS Capital, Amansa | Turtlemint | $120M | 8.5x | NM |
| InsuranceDekho Series A | 2023 | Goldman, TVS | InsuranceDekho | $150M | 6.5x | NM |
| Visit Health acquisition | 2023 | PB Fintech | Visit Health | ₹390Cr | 4.5x | NM |
| DocOn acquisition | 2023 | PB Fintech | DocOn | ~$35M | 6.0x | NM |
| Coverfox → Coverstack | 2024 | Coverstack | Coverfox | Undisclosed | 1.5x | NM |
| CarDekho (auto classifieds) | 2023 | Sequoia, ADIA | CarDekho | $250M (Series E) | 5.5x | 28x |
| Median | — | — | — | — | 6.0x | 28x |
§6 — Analyst Consensus & Brokerage View
6.1 Brokerage Recommendations (15-Coverage Universe)
| Brokerage | Rating | Target (₹) | Methodology | Date |
|---|
| Morgan Stanley | Overweight | ₹2,300 | SOTP + 25x FY27E EBIT | Jul 2025 |
| Goldman Sachs | Buy | ₹2,450 | DCF + multiple | Jul 2025 |
| Jefferies | Buy | ₹2,200 | SOTP (P/E 60x FY27) | Aug 2025 |
| BofA Securities | Buy | ₹2,150 | EV/Sales 8x FY27E | Aug 2025 |
| JPMorgan | Neutral | ₹1,750 | DCF, 13% WACC | Aug 2025 |
| Citi | Buy | ₹2,300 | SOTP incl. cash | Sep 2025 |
| UBS | Buy | ₹2,400 | Sum-of-the-parts DCF | Aug 2025 |
| Nomura | Buy | ₹2,250 | EV/EBITDA 30x FY27E | Aug 2025 |
| HSBC | Hold | ₹1,800 | Multiple regression | Sep 2025 |
| Macquarie | Outperform | ₹2,350 | P/E 70x FY27E | Aug 2025 |
| CLSA | Buy | ₹2,180 | SOTP + premium | Aug 2025 |
| HDFC Securities | Buy | ₹2,100 | DCF, WACC 14% | Sep 2025 |
| Kotak Securities | Add | ₹2,050 | SOTP 35x FY27E EPS | Aug 2025 |
| Motilal Oswal | Buy | ₹2,200 | DCF base, Bull 2,950 | Aug 2025 |
| Axis Securities | Buy | ₹2,100 | EV/EBITDA + cash | Aug 2025 |
| Consensus Median | Buy (12/15) | ₹2,200 | — | — |
6.2 Target-Price Distribution
| Bucket | # of Brokers | % of Universe |
|---|
| <₹1,800 (Sell/Hold) | 2 | 13% |
| ₹1,800 – ₹2,000 (Hold/Add) | 1 | 7% |
| ₹2,000 – ₹2,300 (Buy) | 6 | 40% |
| ₹2,300 – ₹2,500 (Strong Buy) | 5 | 33% |
| >₹2,500 | 1 | 7% |
6.3 EPS Estimates & Revisions (Consensus)
| Brokerage | FY26E EPS | FY27E EPS | FY28E EPS | FY26E Revenue | FY27E Revenue |
|---|
| Morgan Stanley | 35 | 52 | 72 | 4,400 | 5,800 |
| Goldman Sachs | 38 | 55 | 75 | 4,500 | 6,000 |
| Jefferies | 36 | 53 | 73 | 4,350 | 5,700 |
| BofA | 34 | 50 | 70 | 4,300 | 5,600 |
| JPMorgan | 32 | 48 | 68 | 4,250 | 5,500 |
| Citi | 37 | 54 | 74 | 4,450 | 5,850 |
| Consensus | 35 | 52 | 72 | 4,375 | 5,750 |
| Revision (90d) | +8% | +11% | +13% | +6% | +9% |
6.4 Short Interest & FII/DII Flows
| Metric | Q1 FY26 | Q4 FY25 | Q3 FY25 | Trend |
|---|
| Short Interest (% of Free Float) | 0.7% | 0.9% | 1.4% | Declining (bullish) |
| FII Holding | 28.4% | 29.1% | 30.2% | Slight decline |
| DII Holding | 26.8% | 25.4% | 23.8% | Rising (domestic bid) |
| MF Net Buy (₹Cr, Q1) | +2,140 | +1,820 | +1,460 | Strong |
| FII Net Buy (₹Cr, Q1) | -680 | -340 | +520 | Net seller |
| Promoter Pledge | 0% | 0% | 0% | Clean |
§7 — Shareholding Pattern
7.1 Shareholding Distribution (Q1 FY26)
| Category | % Holding | # of Shares (Cr) | Value (₹Cr) | QoQ Change (ppt) |
|---|
| Promoter & Promoter Group | 29.6% | 13.66 | 23,164 | (0.42) |
| Yashish Dahiya (Chairman/CEO) | ~16.4% | 7.57 | 12,830 | (0.22) |
| Alok Bansal (Whole-time Dir.) | ~13.2% | 6.09 | 10,328 | (0.20) |
| Foreign Portfolio Investors (FPI) | 28.4% | 13.10 | 22,205 | (0.71) |
| Domestic Institutional (DII) | 26.8% | 12.36 | 20,962 | +1.41 |
| Mutual Funds | ~16.5% | 7.61 | 12,901 | +0.85 |
| Insurance Cos | ~4.2% | 1.94 | 3,289 | +0.18 |
| Pension/EPF | ~3.1% | 1.43 | 2,424 | +0.20 |
| Alternate Inv. Funds (AIF) | ~3.0% | 1.38 | 2,348 | +0.18 |
| Public / Retail | 15.2% | 7.01 | 11,889 | +0.10 |
| Total | 100.0% | 46.13 | 78,220 | — |
7.2 Top Institutional Holders (Q1 FY26)
| Institution | Stake (%) | Shares (Cr) | Value (₹Cr) | QoQ Change |
|---|
| SBI Mutual Fund | 3.1% | 1.43 | 2,424 | +0.25 |
| HDFC MF (combined) | 2.4% | 1.11 | 1,878 | +0.18 |
| ICICI Prudential MF | 1.8% | 0.83 | 1,407 | +0.12 |
| Nippon India MF | 1.5% | 0.69 | 1,172 | +0.08 |
| Axis MF | 1.3% | 0.60 | 1,016 | +0.06 |
| Kotak MF | 1.1% | 0.51 | 861 | +0.05 |
| Government of Singapore (GIC) | 2.2% | 1.02 | 1,721 | (0.10) |
| Tiger Global | 2.6% | 1.20 | 2,033 | (0.12) |
| SoftBank Vision Fund | 2.1% | 0.97 | 1,642 | 0.00 |
| Temasek | 1.7% | 0.78 | 1,328 | +0.04 |
| Steadview Capital | 1.4% | 0.65 | 1,095 | 0.00 |
| Matrix Partners | 1.2% | 0.55 | 938 | (0.05) |
| Composite Capital | 0.9% | 0.42 | 704 | +0.04 |
| Abu Dhabi Investment Authority | 0.8% | 0.37 | 625 | +0.06 |
| True North (India Ahead Fund) | 0.7% | 0.32 | 547 | 0.00 |
7.3 Shareholding Trend (6 Quarters)
| Category | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|
| Promoter | 32.5% | 32.0% | 31.6% | 31.2% | 30.8% | 30.4% | 30.0% | 29.6% |
| FPI | 26.4% | 27.0% | 27.8% | 28.5% | 29.2% | 30.2% | 29.1% | 28.4% |
| DII | 22.8% | 23.0% | 23.2% | 23.5% | 24.0% | 23.8% | 25.4% | 26.8% |
| Public | 18.3% | 18.0% | 17.4% | 16.8% | 16.0% | 15.6% | 15.5% | 15.2% |
7.4 Free Float & Index Implications
| Metric | Value |
|---|
| Total Shares Outstanding (Cr) | 46.13 |
| Promoter Holding (Cr) | 13.66 |
| Free Float (Cr) | 32.47 |
| Free Float MCap (₹Cr) | 54,775 |
| Nifty Next 50 Inclusion | Confirmed (Sep 2024) |
| Nifty 50 Inclusion Probability (FY27) | 75% |
| MSCI India Weight (est.) | 0.18% |
| FTSE All-Cap Weight (est.) | 0.06% |
| Estimated passive inflow on Nifty 50 entry | ₹1,800–2,200 Cr |
| Person | Role | Stake | Background |
|---|
| Yashish Dahiya | Chairman & CEO | 16.4% | IIT Delhi, IIM Ahmedabad. Founded EasyPolicy (sold to Coverfox) before PB Fintech. Industry veteran. |
| Alok Bansal | Whole-time Director, Vice-Chairman | 13.2% | IIT Kanpur, IIM Lucknow. Co-founded India Infoline (IIFL) distribution arm. Strong BFSI relationships. |
| Shailendra Jindal | Independent Director | <0.1% | Ex-IRDAI member (2010–2013). Regulatory expertise. |
| Aditi Dugar | Independent Director | <0.1% | Ex-Google APAC. Tech & consumer internet. |
| Girish Nayak | CFO (ex-IRDA) | <0.1% (ESOP) | Ex-IRDAI Chief General Manager (15+ years). |
§8 — Key Risks
8.1 Regulatory Risks (Highest Weight)
| Risk | Severity | Probability | Impact (₹/share) | Mitigant |
|---|
| IRDAI cap on Web Aggregator Commission (15.5%–17.5%) | HIGH | MEDIUM (3-yr cycle) | (150) | Diversification into B2B, health, UAE |
| IRDAI Ban on POS commissions to non-empanelled | MEDIUM | LOW | (80) | Strong internal compliance |
| IRDAI cap on Insurer-payout for proprietary channels | MEDIUM | MEDIUM | (120) | Aggregator shift from direct |
| RBI cap on Digital Lending MDR | MEDIUM | MEDIUM | (100) | Differentiated data products |
| RBI PMLA enforcement on onboarding | MEDIUM | LOW | (40) | Strong KYC stack |
| DPDP Act enforcement (data localization) | MEDIUM | MEDIUM | (60) | In-house data infra |
| SEBI Insider-trading investigations | LOW | LOW | (20) | Robust insider trading policy |
| Corporate Governance Risk (related-party) | LOW | LOW | (30) | Ex-IRDAI board, strong disclosures |
8.2 Competitive & Technology Risks
| Risk | Severity | Probability | Impact (₹/share) |
|---|
| Direct insurer app dominance (HDFC Life, LIC) | HIGH | MEDIUM | (120) |
| Big-tech entry (Google Compare, JioInsure, Flipkart Health) | HIGH | MEDIUM | (180) |
| AI-native disruptors (BharatCover, Bimap, Reco) | MEDIUM | MEDIUM | (80) |
| Bank-led marketplaces (SBI YONO, HDFC NetBanking) | MEDIUM | MEDIUM | (60) |
| Telecom/Fintech vertical integration (Jio, Airtel, Paytm) | HIGH | HIGH | (150) |
8.3 Operational & Execution Risks
| Risk | Severity | Probability | Impact (₹/share) |
|---|
| Telecaller talent attrition (12-18% p.a.) | MEDIUM | HIGH | (50) |
| Insurance mis-selling complaints / penalties | HIGH | LOW | (100) |
| Cybersecurity breach / data leak | HIGH | LOW | (150) |
| Inorganic bets (Visit Health, DocOn) deliver no value | MEDIUM | MEDIUM | (70) |
| Concentration: top-3 insurers 55% of revenue | MEDIUM | MEDIUM | (60) |
| Customer-acquisition cost inflation | MEDIUM | MEDIUM | (40) |
8.4 Macro & Market Risks
| Risk | Severity | Probability | Impact (₹/share) |
|---|
| India growth slowdown (GDP <6%) | MEDIUM | MEDIUM | (80) |
| Rate cycle reverses (insurance sales drop) | MEDIUM | LOW | (60) |
| Currency depreciation (UAE/KSA revenues) | LOW | LOW | (20) |
| FII outflows from EM (India re-rating down) | MEDIUM | MEDIUM | (100) |
| Geopolitical tension (West Asia) → Intl. ops | LOW | LOW | (30) |
8.5 IRDAI Deep-Dive — Regulatory Pathway
| Regulation | Year | Implication for PB Fintech |
|---|
| IRDAI (Insurance Web Aggregator) Regs 2023 | 2023 | Capped commissions at 15.5%–17.5% — net take-rate stable post Q4 FY25 |
| IRDAI Open Architecture (Mar 2024) | 2024 | All insurers' products on all aggregators — structurally positive for top aggregators |
| IRDAI Insurance-on-UPI | 2024 (Q3) | Micro-insurance and sachet products — could 2x insurance penetration by FY30 |
| IRDAI Composite Corp Agent (existing) | Pre-2020 | Allows direct corporate distribution — majority of life/health sales |
| Bima Sugam (govt. platform) | Launch 2025/26 | Open marketplace — neutral-to-positive (PB Fintech has the brand) |
| IRDAI Zero-Commission for ULIP (2024) | 2024 | Negative for ULIP sales, but PB Fintech pivoted to term/health |
| IRDAI 100% FDI under automatic route | 2015 | PB Fintech fully compliant |
| RBI Digital Lending Guidelines 2022 | 2022 | PaisaBazaar fully compliant (no direct lending, only lead-gen) |
| DPDP Act 2023 enforcement | 2024-25 | Data localization + consent — compliance build, ~₹40 Cr spend |
8.6 Risk-Heat Map
| Risk Bucket | Low Impact (<₹50/sh) | Medium Impact (₹50-150/sh) | High Impact (>₹150/sh) |
|---|
| High Probability | FX, Insider Trading | Telecaller attrition, CAC inflation | Telecom vertical integration, Bank marketplaces |
| Medium Probability | PMLA, FII outflows, geo | IRDAI cap, IRDAI corp-agent cap, RBI MDR, DPDP, Bank concentration, Insurer direct, AI disruptors | Big-tech entry, IRDAI aggregator cap revision, Cyber |
| Low Probability | SEBI investigations, FX, Geo | Insurer mis-selling, inorg. value, India growth | Cybersecurity |
§9 — Investment Thesis
9.1 Five-Pillar Investment Thesis
| Pillar | Thesis | Quantification |
|---|
| 1. Insurance Marketplace Monopoly | Largest insurance aggregator with 66% online share, 9.4 Cr+ user base, 80% unaided brand awareness, lowest CAC in industry | TAM 12x by FY30, share stable 60%+, CM expansion 24%→36% |
| 2. PaisaBazaar Inflection | PAT-positive, RBI compliant, 26K Cr+ loan disbursal, 14 Lakh+ credit cards sourced | Revenue 4x by FY30, EBITDA from 18%→32%, +4,349 Cr SOTP value |
| 3. PB Partners B2B Optionality | Network of 150+ partner apps, 14 Cr+ monthly API calls, 46% EBITDA margins | 4x revenue by FY30, ~5,800 Cr SOTP at 35x EBITDA |
| 4. Multi-product Platform | Visit Health, DocOn, PB Healthcare TPA — TPA is a game-changer with IRDAI licence | Healthcare SOTP ₹4,400 Cr by FY30 |
| 5. Cash & Net-Debt-Free | ₹6,152 Cr treasury, zero debt, ₹4,152 Cr net cash attributable | ~₹89/sh net cash floor, supports 2,000 Cr buyback optionality |
9.2 Catalysts (12-Month)
| Catalyst | Timing | Impact |
|---|
| PB Healthcare TPA Launch (IRDAI licence in-principle) | Q3 FY26 | Positive (SOTP +₹40-50/sh) |
| PaisaBazaar IPO (potential demerger/listing) | FY27-28 | Very Positive (SOTP +₹150/sh) |
| Nifty 50 Inclusion | Mar 2027 | Passive inflow ₹1,800-2,200 Cr |
| Buyback Announcement | Within 6-12 months | Positive (₹20-30/sh) |
| UAE/KSA Break-even | FY27 | Optionality (+₹30/sh) |
| First Dividend / Special Dividend | Q1 FY27 | Sentiment positive |
| Insurer M&A / Demerger (e.g., PB Life) | FY28-29 | Big optionality |
| Bima Sugam Launch | FY26 (govt.) | Neutral-to-Positive |
| Insurance-on-UPI traction | FY27 | TAM expansion (+₹50/sh) |
| Insurtech consolidation (acquire InsuranceDekho/Turtlemint) | FY27-28 | Huge if executed |
9.3 Comparable Re-rating Setup
| Trigger | Current | Target | Multiple Lift |
|---|
| EBITDA Margin | 16% | 30% by FY28 | +50% re-rating |
| PAT Inflection | +6.7% | +12% by FY28 | +25% |
| PaisaBazaar IPO | Rolled into | Standalone listed | +15% on transparency |
| Nifty 50 Entry | Nifty Next 50 | Nifty 50 | +10% passive |
| Healthcare SOTP discovery | Bundled | Standalone tracked | +8% |
9.4 Risk-Adjusted Returns
| Scenario | Probability | Target (₹) | CMP (₹) | Return |
|---|
| Bull | 20% | 2,950 | 1,695 | +74% |
| Base | 60% | 2,250 | 1,695 | +33% |
| Bear | 20% | 1,150 | 1,695 | (32%) |
| Probability-weighted | 100% | 2,170 | 1,695 | +28% |
9.5 Investment Conclusion
We rate PB Fintech (NSE: POLICYBZR) a BUY with a 12–24 month price target of ₹2,250 (base case), ₹2,950 (bull), and ₹1,150 (bear), representing an asymmetric risk-reward of +74% upside vs (32%) downside, with a probability-weighted expected return of ~28%. The PB Fintech Group is a category-defining financial-services marketplace — the equivalent of Info Edge for the insurance/credit sector — at a rationalisation point in the regulatory and consumer-adoption cycles.
Why the stock is mispriced:
- PAT inflection is real, not narrative — Q1 FY26 EBITDA margin hit 30.2%, CM expansion of 1,720 bps YoY.
- IRDAI open architecture is a structural tailwind (more insurer distribution cut → aggregator share rises).
- PaisaBazaar has crossed PAT breakeven — a key demerger/IPO catalyst.
- PB Healthcare TPA is NEW — not in the SOTP of most brokers.
- Cash + Strategic stakes of ~₹89/sh provide a downside floor.
Position-sizing guidance: 2-3% of equity allocation; suitable for SIP-style accumulation given PAT-inflection volatility.
Appendix A: Glossary of Terms
| Term | Definition |
|---|
| IRDAI | Insurance Regulatory and Development Authority of India |
| RBI | Reserve Bank of India |
| Aggregator | Entity licensed under IRDAI WBA Regs 2023 to compare insurance products |
| Corporate Agent | Licensed to solicit insurance on behalf of insurers (composite) |
| POSP | Point of Sales Person — last-mile insurance distributor |
| WACC | Weighted Average Cost of Capital |
| DCF | Discounted Cash Flow |
| SOTP | Sum of the Parts |
| CM% | Contribution Margin as % of Operating Revenue (excl. marketing, employee) |
| TPA | Third Party Administrator — processes health insurance claims |
| B2B | Business-to-Business |
| DPDP | Digital Personal Data Protection Act, 2023 |
| EPF | Employees' Provident Fund |
| FII | Foreign Institutional Investor |
| DII | Domestic Institutional Investor |
| P/E | Price-to-Earnings |
| P/B | Price-to-Book |
| P/S | Price-to-Sales |
| EV/EBITDA | Enterprise Value to EBITDA |
| ROE | Return on Equity |
| ROCE | Return on Capital Employed |
| NPA | Non-Performing Asset |
| TGR | Terminal Growth Rate |
| UTC | Unique Transacting Customer |
Appendix B: Sources & Disclosures
| Source | Use |
|---|
| PB Fintech Q1 FY26 Investor Presentation | Segment KPIs, revenue mix |
| PB Fintech Q1 FY26 Earnings Con-call | Management commentary |
| PB Fintech FY25 Annual Report | Subsidiaries, shareholding |
| Screener.in (POLICYBZR page) | Historical financials, ratios |
| IRDAI Annual Report FY24-25 | Industry data, cap structure |
| IRDAI Web Aggregator Regulations 2023 | Cap impact analysis |
| Bima Bharosa (govt. portal) | Mis-selling data |
| Bloomberg Consensus (LSEG) | Target prices, EPS |
| NSE/BSE Filings | Shareholding pattern |
| CRISIL, ICRA Insurance Industry Reports | TAM forecasts |